Home › DNAmbiguous: FDA orders 23AndMe to submit its product for evaluation and efficacy testing
 

Keywords :   


DNAmbiguous: FDA orders 23AndMe to submit its product for evaluation and efficacy testing

2013-11-25 19:23:58| Extremetech

The FDA has yanked its approval of 23andMe's product, giving the company 15 days to produce data that demonstrates the efficacy of its testing or face further penalties.

Tags: product submit orders evaluation

Category:Information Technology

Latest from this category

All news
»
05.10Atlantic Tropical Weather Outlook
05.10Tropical Storm Milton Update Statement
05.10Summary for Tropical Storm Milton (AT4/AL142024)
05.10Eastern North Pacific Tropical Weather Outlook
05.10Tropical Depression Fourteen Graphics
05.10Tropical Depression Fourteen Forecast Discussion Number 1
05.10Tropical Depression Fourteen Wind Speed Probabilities Number 1
05.10Tropical Depression Fourteen Public Advisory Number 1
More »